LBRX R&D Expenses

Lb Pharmaceuticals Inc · R&D Expenses

LBRX logo

LBRX R&D Expenses

Latest reported$69.69M
LBRX TTM R&D Expenses ($53.72M → $69.69M)
High-resolution chart · PNG

LBRX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lb Pharmaceuticals Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
69,693,000
28,468,000
16,744,000
18,925,000
40,966,000
53,716,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.